Hot biotech market: (from left) The flags of the Hong Kong Stock Exchange (HKEX), China and Hong Kong are seen hoisted in Hong Kong. At least 16 biotech firms are pursuing IPOs in the former British colony, seeking to raise upwards of US3bil. — AFP
HONG KONG: Investment bankers in Hong Kong are catching biotech fever.
At least seven senior bankers and analysts from top-tier securities firms have quit to join biotechnology companies in the city since December, responding to the industry’s growing demand for financial expertise after rule changes at Hong Kong’s stock exchange smoothed the path for biotech initial public offerings.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
